These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 22685388)

  • 1. Standing genetic variation and the evolution of drug resistance in HIV.
    Pennings PS
    PLoS Comput Biol; 2012; 8(6):e1002527. PubMed ID: 22685388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nevirapine resistance viral mutations after repeat use of nevirapine for prevention of perinatal HIV transmission.
    Kuhn L; Sinkala M; Kankasa MP; Kasonde P; Thea DM; Aldrovandi GM
    J Acquir Immune Defic Syndr; 2006 Jun; 42(2):260-2. PubMed ID: 16760802
    [No Abstract]   [Full Text] [Related]  

  • 3. Selection and persistence of viral resistance in HIV-infected children after exposure to single-dose nevirapine.
    Martinson NA; Morris L; Gray G; Moodley D; Pillay V; Cohen S; Dhlamini P; Puren A; Bhayroo S; Steyn J; McIntyre JA
    J Acquir Immune Defic Syndr; 2007 Feb; 44(2):148-53. PubMed ID: 17117145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minor drug-resistant HIV type-1 variants in breast milk and plasma of HIV type-1-infected Ugandan women after nevirapine single-dose prophylaxis.
    Pilger D; Hauser A; Kuecherer C; Mugenyi K; Kabasinguzi R; Somogyi S; Harms G; Kunz A
    Antivir Ther; 2011; 16(1):109-13. PubMed ID: 21311114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of 3 regimens to prevent nevirapine resistance mutations in HIV-infected pregnant women receiving a single intrapartum dose of nevirapine.
    Van Dyke RB; Ngo-Giang-Huong N; Shapiro DE; Frenkel L; Britto P; Roongpisuthipong A; Beck IA; Yuthavisuthi P; Prommas S; Puthanakit T; Achalapong J; Chotivanich N; Rasri W; Cressey TR; Maupin R; Mirochnick M; Jourdain G;
    Clin Infect Dis; 2012 Jan; 54(2):285-93. PubMed ID: 22144539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of HIV drug resistance mutations in pregnant women receiving single dose Nevirapine in south India.
    Jacob MS; Durairaj A; Vijayakumari J; Srijayanth P; Sivakumar MR
    Indian J Pathol Microbiol; 2011; 54(2):359-61. PubMed ID: 21623090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minority HIV-1 drug-resistant mutations and prevention of mother-to-child transmission: perspectives for resource-limited countries.
    Samuel R; Paredes R; Parboosing R; Moodley P; Gordon M
    AIDS Rev; 2014; 16(4):187-98. PubMed ID: 25300623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nevirapine-induced resistance is a problem.
    S Afr Med J; 2004 May; 94(5):338. PubMed ID: 15211947
    [No Abstract]   [Full Text] [Related]  

  • 9. [Drug resistance of HIV-1 as a result of using nevirapine for chemoprophylaxis of vertical viral transmission from HIV-infected mother to infant].
    Kazennova EV
    Vopr Virusol; 2009; 54(1):45-8. PubMed ID: 19253732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to antiretroviral therapy after a single, peripartum dose of nevirapine.
    Lockman S; Shapiro RL; Smeaton LM; Wester C; Thior I; Stevens L; Chand F; Makhema J; Moffat C; Asmelash A; Ndase P; Arimi P; van Widenfelt E; Mazhani L; Novitsky V; Lagakos S; Essex M
    N Engl J Med; 2007 Jan; 356(2):135-47. PubMed ID: 17215531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Slower clearance of nevirapine resistant virus in infants failing extended nevirapine prophylaxis for prevention of mother-to-child HIV transmission.
    Persaud D; Bedri A; Ziemniak C; Moorthy A; Gudetta B; Abashawl A; Mengistu Y; Omer SB; Isehak A; Kumbi S; Adamu R; Lulseged S; Ashworth R; Hassen E; Ruff A;
    AIDS Res Hum Retroviruses; 2011 Aug; 27(8):823-9. PubMed ID: 21241214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIVNET 012 and Petra.
    Cooper E
    Lancet; 2004 Jan; 363(9404):244; author reply 245-6. PubMed ID: 14738806
    [No Abstract]   [Full Text] [Related]  

  • 13. Lower risk of resistance after short-course HAART compared with zidovudine/single-dose nevirapine used for prevention of HIV-1 mother-to-child transmission.
    Lehman DA; Chung MH; Mabuka JM; John-Stewart GC; Kiarie J; Kinuthia J; Overbaugh J
    J Acquir Immune Defic Syndr; 2009 Aug; 51(5):522-9. PubMed ID: 19502990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In utero HIV infection is associated with an increased risk of nevirapine resistance in ugandan infants who were exposed to perinatal single dose nevirapine.
    Church JD; Mwatha A; Bagenda D; Omer SB; Donnell D; Musoke P; Nakabiito C; Eure C; Bakaki P; Matovu F; Thigpen MC; Guay LA; McConnell M; Fowler MG; Jackson JB; Eshleman SH
    AIDS Res Hum Retroviruses; 2009 Jul; 25(7):673-7. PubMed ID: 19552593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Greater suppression of nevirapine resistance with 21- vs 7-day antiretroviral regimens after intrapartum single-dose nevirapine for prevention of mother-to-child transmission of HIV.
    McMahon DK; Zheng L; Hitti J; Chan ES; Halvas EK; Hong F; Kabanda J; Taulo F; Kumarasamy N; Bonhomme J; Wallis CL; Klingman KL; Hughes MD; Mellors JW
    Clin Infect Dis; 2013 Apr; 56(7):1044-51. PubMed ID: 23300238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 drug resistance emergence among breastfeeding infants born to HIV-infected mothers during a single-arm trial of triple-antiretroviral prophylaxis for prevention of mother-to-child transmission: a secondary analysis.
    Zeh C; Weidle PJ; Nafisa L; Lwamba HM; Okonji J; Anyango E; Bondo P; Masaba R; Fowler MG; Nkengasong JN; Thigpen MC; Thomas T
    PLoS Med; 2011 Mar; 8(3):e1000430. PubMed ID: 21468304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal versus suboptimal treatment for HIV-infected pregnant women and HIV-exposed infants in clinical research studies.
    Ammann AJ
    J Acquir Immune Defic Syndr; 2009 Aug; 51(5):509-12. PubMed ID: 19521253
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug resistance mutations 18 months after discontinuation of nevirapine-based ART for prevention of mother-to-child transmission of HIV in Malawi.
    Palombi L; Galluzzo CM; Andreotti M; Liotta G; Jere H; Sagno JB; Luhanga R; Mancinelli S; Amici R; Marazzi MC; Vella S; Giuliano M
    J Antimicrob Chemother; 2015 Oct; 70(10):2881-4. PubMed ID: 26111981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrapartum tenofovir and emtricitabine reduces low-concentration drug resistance selected by single-dose nevirapine for perinatal HIV prevention.
    Chi BH; Ellis GM; Chintu N; Cantrell RA; Sinkala M; Aldrovandi GM; Warrier R; Mbewe F; Nakamura K; Stringer EM; Frenkel LM; Stringer JS
    AIDS Res Hum Retroviruses; 2009 Nov; 25(11):1099-106. PubMed ID: 19886836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
    ; de Vincenzi I
    Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.